文献速递生殖医学妇科

靶向二代测序提高男性不育中CFTR变异检出:病例系列

Improved detection of CFTR variants by targeted next-generation sequencing in male infertility: a case series.
PubMed 文献 · Reprod Biomed Online · 2019-08-22

在1112例特发性无精子症或严重少精子症男性中,靶向二代测序(NGS)检出5例携带CFTR致病变异、而常规突变面板筛查未诊断的患者。5例中NGS均发现额外致病变异,提示对无精子症男性考虑CFTR全基因分析而非突变面板筛查。

要点

  • 1112例特发性无精子症或严重少精子症男性中,靶向NGS检出5例CFTR变异携带者。
  • 5例中NGS均发现额外致病变异,而常规CFTR突变面板筛查结果为阴性或未提供检测。
  • 数据提示对无精子症男性应考虑CFTR全基因分析而非突变面板筛查。

核心结论

  • 靶向NGS检出5例在常规遗传筛查后仍未诊断的CFTR变异男性不育患者。
  • 鉴于靶向NGS广泛可及且价格可负担,数据提示对无精子症男性应考虑CFTR全基因分析而非突变面板筛查。

研究设计与样本

  • 病例系列:在1112例特发性无精子症或严重少精子症男性中,通过靶向NGS检出5例携带杂合致病CFTR变异的个体。
  • 预筛排除标准为:临床检查诊断为CBAVD且作为常规生育检查一部分的CFTR序列分析阳性。

主要发现

  • 病例1、2、3表现为CBAVD,其CFTR突变面板分析为阴性。
  • 病例4表现为先天性单侧输精管缺如,CFTR面板分析检出杂合p.(Phe508del)变异。
  • 病例5输精管可触及,未提供CFTR面板分析。
  • 5例中靶向NGS均发现额外致病变异:病例1为p.(Arg117Cys)和p.(Arg1158*);病例2为p.(Asp110His)和p.(Ser945Leu);病例3为p.(Arg248Thr)和p.(Phe508Cys);病例4为p.(Gly463Ser)和p.(Phe508del);病例5为p.(Phe508del)和p.(Arg117His)。

关键数值与推荐

  • 队列样本量为1112例特发性无精子症或严重少精子症男性。
  • 检出5例携带杂合致病CFTR变异的个体。

临床怎么用

  • 对无精子症或严重少精子症男性,在生育检查中可考虑采用靶向NGS进行CFTR全基因分析以筛查变异。
  • 数据提示全基因分析而非突变面板筛查可减少CFTR变异漏诊。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RESEARCH QUESTION: Congenital bilateral absence of vas deferens (CBAVD) is characterized by 'obstructive azoospermia' in male patients with primary infertility. In the routine clinical workup of infertile men, patients with an absence of vas deferens are screened for CFTR variants. However, current genetic testing panels do not cover all variants, missing some CBAVD cases. Here, CFTR testing was explored by targeted next-generation sequencing (NGS) to improve variant detection. DESIGN: Five individuals with heterozygous pathogenic CFTR variants were identified using targeted NGS in a cohort of 1112 idiopathic infertile men with azoospermia or severe oligozoospermia. Pre-screening exclusion criteria were CBAVD by clinical examination with positive CFTR sequence analysis as part of routine fertility workup. RESULTS: Cases 1, 2 and 3 presented with CBAVD after which CFTR screening by mutation panel analysis was negative. Case 4 presented with congenital unilateral absence of vas deferens, after which CFTR panel analysis identified a heterozygous p.(Phe508del) variant. Case 5 presented with a palpable vas deferens so CFTR panel analysis was not offered. In all five men, targeted NGS revealed additional pathogenic variants: p.(Arg117Cys) and p.(Arg1158*) (case 1); p.(Asp110His) and p.(Ser945Leu) (case 2); p.(Arg248Thr) and p.(Phe508Cys) (case 3); p.(Gly463Ser) (case 4); p.(Phe508del) (case 4 and 5); and p.(Arg117His) (case 5). CONCLUSIONS: Targeted NGS led to the detection of five infertile men with CFTR variants who would otherwise have remained undiagnosed after routine genetic screening during the fertility workup for azoospermia or severe oligozoospermia. Given the wide availability of affordable targeted NGS, the data suggest that full gene analysis, and not mutation panels, should be considered to screen CFTR in azoospermic men.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Smits RM, Oud MS, Vissers LELM, et al. Improved detection of CFTR variants by targeted next-generation sequencing in male infertility: a case series. Reprod Biomed Online. 2019. PMID: 31672438. doi:10.1016/j.rbmo.2019.08.005

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。